Bruceantin inhibits multiple myeloma cancer stem cell proliferation. (Record no. 26243516)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01171 a2200325 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517105306.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201709s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1555-8576 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1080/15384047.2016.1210737 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Issa, Mark E |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20170905 |
| 245 00 - TITLE STATEMENT | |
| Title | Bruceantin inhibits multiple myeloma cancer stem cell proliferation. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer biology & therapy |
| Date of publication, distribution, etc. | 09 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 966-75 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Phytogenic |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Proliferation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Human Umbilical Vein Endothelial Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multiple Myeloma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplastic Stem Cells |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Quassins |
| General subdivision | pharmacology |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berndt, Sarah |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carpentier, Gilles |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pezzuto, John M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cuendet, Muriel |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer biology & therapy |
| Related parts | vol. 17 |
| -- | no. 9 |
| -- | p. 966-75 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1080/15384047.2016.1210737">https://doi.org/10.1080/15384047.2016.1210737</a> |
| Public note | Available from publisher's website |
No items available.